Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
JACC. Advances|July 17, 2025
Safety and Feasibility of Transcatheter Edge-to-Edge Repair of Mitral Regurgitation in Cardiac AmyloidosisJulia Vogel, Peter Luedike, Katharina Hellhammer, et al.
Cancer Genetics and Cytogenetics|December 16, 2010
Gene dosage effects in chronic lymphocytic leukemiaLudger Sellmann, Rene Scholtysik, Markus Kreuz, et al.
Haematologica|July 13, 2023
Daratumumab in first-line treatment of patients with light chain amyloidosis and Mayo stage IIIb improves treatment response and overall survivalSara Oubari, Ute Hegenbart, Renate Schoder, et al.
EMBO Molecular Medicine|April 9, 2015
Regulation of hematogenous tumor metastasis by acid sphingomyelinaseAlexander Carpinteiro, Katrin Anne Becker, Lukasz Japtok, et al.
Cancers|April 23, 2022
Mitochondrial Kv1.3 Channels as Target for Treatment of Multiple MyelomaStephanie Kadow, Fabian Schumacher, Melanie Kramer, et al.
Hemoglobin|April 15, 2020
Veno-Venous Extracorporeal Membrane Oxygenation in Adult Patients with Sickle Cell Disease and Acute Chest Syndrome: a Single-Center ExperienceFerras Alashkar, Frank Herbstreit, Alexander Carpinteiro, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|October 7, 2020
18F-flutemetamol positron emission tomography in cardiac amyloidosisMaria Papathanasiou, Lukas Kessler, Alexander Carpinteiro, et al.
Translational Psychiatry|March 4, 2022
Association between FIASMA psychotropic medications and reduced risk of intubation or death in individuals with psychiatric disorders hospitalized for severe COVID-19: an observational multicenter studyNicolas Hoertel, Marina Sánchez-Rico, Erich Gulbins, et al.
European Journal of Haematology|June 29, 2021
Impact of time to diagnosis on Mayo stages, treatment outcome, and survival in patients with AL amyloidosis and cardiac involvementSara Oubari, Eyad Naser, Maria Papathanasiou, et al.
Blood|February 29, 2020
Daratumumab for systemic AL amyloidosis: prognostic factors and adverse outcome with nephrotic-range albuminuriaChristoph R Kimmich, Tobias Terzer, Axel Benner, et al.
Pageof 9